Citations

Clear

421 citation(s) found for "Short, C".

Metastatic Spine Disease: Should Patients With Short Life Expectancy Be Denied Surgical Care? An International Retrospective Cohort Study
Dea, Nicolas , Versteeg, Anne , Sahgal, Arjun , Verlaan, Jorrit‐Jan , Charest-Morin, Raphaële , Rhines, Laurence D. , Sciubba, Daniel M. , Schuster, James M. , Weber, Michael H. , Lazáry, Áron , Laufer, Ilya , Gokaslan, Ziya L. , Fisher, Charles G. , Tumor, on behalf of the AOSpine Knowledge Forum, Versteeg, Anne L. , Lazary, Aron , Fehlings, Michael G. , Clarke, Michelle J. , Arnold, Paul M. , Boriani, Stefano , Bettegowda, Chetan , Tumor, on behalf of the AOSpine Knowledge Forum

Mayo Clinic

Neurosurgery | October 1, 2019 | Volume: 87 | Issue: 2 | Pages: 303-311

10.1093/neuros/nyz472 | PMID 31690935 Get It

Abstract BACKGROUND Despite our inability to accurately predict survival in many cancer patients, a life expectancy of at least 3 mo is historically necessary to be considered for surgical treatment of spinal metastases. OBJECTIVE To compare health-related quality of life (HRQOL) in patients surviving <3 mo after surgical treatment to patients surviving >3 mo to assess the validity of this inclusion criteria. METHODS Patients who underwent surgery for spinal metastases between August 2013 and May 2017 were retrospectively identified from an international cohort study. HRQOL was evaluated using generic and disease-specific outcome tools at baseline and at 6 and 12 wk postsurgery. The primary outcome was the HRQOL at 6 wk post-treatment measured by the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ). RESULTS A total of 253 patients were included: 40 patients died within the first 3 mo after surgery and 213 patients survived more than 3 mo. Patients surviving <3 mo after surgery presented with lower baseline performance status. Adjusted analyses for baseline performance status did not reveal a significant difference in HRQOL between both groups at 6 wk post-treatment. No significant difference in patient satisfaction at 6 wk with regard to their treatment could be detected between both groups. CONCLUSION When controlled for baseline performance status, quality of life 6 wk after surgery for spinal metastasis is independent of survival. To optimize improvement in HRQOL for this patient population, baseline performance status should take priority over expected survival in the surgical decision-making process.
Case report: Paradoxical responses to short acting beta-agonists in a pediatric patient
Graden, Alexandra, Gandhi, Sonia , Joshi, Avni Y. , Gandhi, Sonia

Mayo Clinic

Journal of Asthma | October 1, 2019 | Volume: 58 | Issue: 2 | Pages: 213-215

10.1080/02770903.2019.1668009 | PMID 31573361 Get It

Prediction of Short- and Long-Term Mortality in Takotsubo Syndrome: The InterTAK Prognostic Score
Wischnewsky, Manfred , Candreva, Alessandro , Bacchi, Beatrice , Cammann, Victoria L. , Kato, Ken , Szawan, Konrad A. , Gili, Sebastiano , Citro, Rodolfo , Bossone, Eduardo , Franke, Jennifer , Sorici‐Barb, Ioana, Knorr, Maike, Heiner, Susanne, Burgdorf, Christof , Kherad, Behrouz , Tschöpe, Carsten , Sarcon, Annahita, Shinbane, Jerold S., Rajan, Lawrence, Michels, Guido, Pfister, Roman , Cuneo, Alessandro , Jacobshagen, Claudius, Karakas, Mahir , Köenig, Wolfgang , Pott, Alexander , Meyer, Philippe , Arroja, José David , Banning, Adrian , Cuculi, Florim , Kobza, Richard , Fischer, Thomas, Vasankari, Tuija , Airaksinen, Juhani , Napp, L. Christian , Budnik, Monika , Dworakowski, Rafał , MacCarthy, Philip , Osswald, Stefan , Galiuto, Leonarda , Chan, Christina , Bridgman, Paul , Beug, Daniel , El‐Battrawy, Ibrahim , Akın, İbrahim , Gilyarova, Ekaterina, Gilyarov, Mikhail , Kozel, Martin , Winchester, David E. , Ukena, Christian , Poglajen, Gregor , Carrilho‐Ferreira, Pedro , Hauck, Christian , Paolini, Carla , Bilato, Claudio , Prasad, Abhiram , Rihal, Charanjit S. , Bianco, Matteo , Jörg, Lucas, Rickli, Hans , Kobayashi, Yoshio, Böhm, Michael , Maier, Lars S. , Pinto, Fausto J. , Widimský, Petr , Borggrefe, Martin, Felix, Stephan B. , Opolski, Grzegorz , Rottbauer, Wolfgang , Pieske, Burkert , Katus, Hugo A. , Horowitz, John D. , Münzel, Thomas , Crea, Filippo , Lüscher, Thomas F. , Ghadri, Jelena R. , Templin, Christian , Gilyarov, Mikhail , Bossone, Eduardo , Citro, Rodolfo , El-Battrawy, Ibrahim , Prasad, Abhiram , Tschöpe, Carsten , Koenig, Wolfgang , Meyer, Philippe , Banning, Adrian , Kobza, Richard , Gilyarov, Mikhail , Ukena, Christian , Bilato, Claudio , D’Ascenzo, Fabrizio , Dichtl, Wolfgang , Neuhaus, Michael, Jaguszewski, Miłosz , Noutsias, Michel , Kaiser, Christoph A. , Delmas, Clément , Lairez, Olivier , Shilova, Alexandra S. , Toušek, Petr , Gałuszka, Jan , Rihal, Charanjit S. , Liu, Kan , Schulze, Paul Christian , Nguyen, Thanh Ha Tuan , Braun-Dullaeus, Ruediger Christian , Hasenfuß, Gerd , Schunkert, Heribert , Thiele, Hölger , Bauersachs, Johann , Mario, Carlo Di , Bax, Jeroen J. , Ruschitzka, Frank T. , Bianco, Matteo

Mayo Clinic

European Journal of Heart Failure | August 27, 2019 | Volume: 21 | Issue: 11 | Pages: 1469-1472

10.1002/ejhf.1561 | PMID 31452320 Get It

Short‐term safety and long‐term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study
Saadat, Nasser, Saadatagah, Seyedmohammad , Nargesi, Arash Aghajani , Alidoosti, Mohammad , Poorhosseini, Hamidreza , Amirzadegan, Alireza , Ghodsi, Saeed , Salarifar, Mojtaba , Aghajani Nargesi, Arash, Ghodsi, Saeed , Lashkari, Reza, Mortazavi, Seyedeh Hamideh , Jalali, Arash

Mayo Clinic

Catheterization and Cardiovascular Interventions | July 18, 2019 | Volume: 95 | Issue: 7 | Pages: 1249-1256

10.1002/ccd.28396 | PMID 31318488 Get It

AbstractAimAchieving the optimal apposition of coronary stents during percutaneous coronary intervention is not always feasible. The risks and benefits of stent postdilation in primary percutaneous coronary intervention (PPCI) in patients with ST‐elevation myocardial infarction (STEMI) have remained controversial. We sought to evaluate the immediate angiographic and long‐term outcomes in patients with and without stent postdilation.MethodsA cohort of patients (n = 1,224) with STEMI, treated with PPCI (n = 500 postdilated; n = 724 controls), were studied. The flow grade, the myocardial blush grade, and the frame count were considered angiographic outcomes. The clinical outcomes were major adverse cardiovascular events (MACE)—comprising cardiac death, nonfatal MI, and repeat revascularization—and the device‐oriented composite endpoint (DOCE)—consisting of cardiac death, target lesion revascularization, and target vessel revascularization.ResultsThe flow and myocardial blush grades were not different between the two groups, and the frame count was significantly lower in the postdilation group (15.7 ± 8.4 vs. 17 ± 10.4; p < .05). The patients were followed up for 348 ± 399 days. DOCE (2.2% vs. 5.8%) and cardiac mortality (1.2% vs. 3.2%) were lower in the postdilation group. In the fully adjusted propensity score‐matched analysis, postdilation was associated with decreased DOCE (HR = 0.40 [0.18–0.87], p = .021).ConclusionsSelective postdilation improved some angiographic and clinical outcomes and could not be discouraged in PPCI on patients with STEMI.
An Unusual Case of Median Neuropathy: Application of Short Segmental Sensory Nerve Stimulation
Luetmer, Marianne T. , Laughlin, Ruple S.

Mayo Clinic

Journal of Clinical Neurophysiology | July 8, 2019 | Volume: 36 | Issue: 6 | Pages: 468-470

10.1097/wnp.0000000000000616 | PMID 31274708 Get It

Summary: A 55-year-old woman presented with an 18-month history of intermittent left-hand paresthesias affecting her first, second, and third digits. A small, immobile, nontender midline mass on the volar aspect of the left wrist was also present. Evaluation included normal routine nerve conduction studies and needle electromyography. An ultrasound was performed in the electromyography laboratory, verifying median nerve involvement of the mass within the proximal carpal tunnel. This finding guided the electromyographer to perform the unconventional technique of sensory nerve short segmental stimulation across the carpal tunnel, which confirmed focal slowing across the lesion, achieving electrodiagnostic confirmation of median nerve impairment. This case of atypical carpal tunnel syndrome due to a median nerve schwannoma demonstrates both the utility and specificity of short segmental sensory stimulation in some cases of median neuropathy at the wrist and the value of sonography in the electromyography laboratory.
Short versus long duration of adjuvant trastuzumab (T) in HER2+ breast cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Sipra, Qurat Ul Ain Riaz , Raina, Ammad, Khan, Ahsan Masood , Akhtar, Maheen, Leon‐Ferre, Roberto A. , Riaz, Irbaz Bin , Husnain, Muhammad , Wang, Zhen , Murad, M. Hassan

Mayo Clinic

Journal of Clinical Oncology | May 27, 2019 | Volume: 37 | Issue: 15_suppl | Pages: e12057-e12057

10.1200/jco.2019.37.15_suppl.e12057 Get It

e12057 Background: Several RCTs have evaluated a shorter duration of T ( < 12 months) with hopes of similar efficacy, reduced cardiotoxicity, cost and burden of treatment. Of the 5 major studies, PERSPHONE showed that 6 months was non-inferior compared to 12 months. However, four additional studies of shorter duration failed to demonstrate non-inferiority. Therefore, we performed an updated systematic review and a meta-analysis to assess the optimal duration of adjuvant T. Methods: MEDLINE, EMBASE, Cochrane, Scopus and conference proceedings were searched to identify RCTs comparing one year of adjuvant T with a shorter duration in early-stage HER2+ breast cancer. The DerSimonian-Laird random-effects Meta-Analysis was performed using CMAv3 software to derive pooled Hazard Ratio (HR) estimates for overall survival (OS, Disease-Free Survival (DFS) and Odds Ratio(OR) estimates of cardiac toxicity. Q-test was used to assess between-study heterogeneity; I2 statistic was computed to express the percentage of the total observed variability due to study heterogeneity. The risk for bias was assessed using the Cochrane Collaboration’s tool. Results: We screened 1772 citations and identified 5 studies(n = 11,377) for analysis. 5691 patients were randomized to 12 months of adjuvant T while 5686 were randomized to a shorter duration (3 studies evaluated 6 vs 12 months, 2 studies evaluated 9 weeks vs 12 months). OS (HR, 1.16, 95% CI 1.03-1.31, P= 0.015,I2 0.00, p= 0.837) and DFS (HR, 1.14, 95% CI 1.02-1.26 , P = 0.016,I2 14.90, p= 0.319) were significantly worse in patients receiving shorter duration T as compared to 12 months. Cardiotoxicity was significantly higher in the 12 month group vs shorter duration (OR, 2.10, 95% CI 1.58-2.80, p = 0.000 ,I2 51.182, p= 0.085). Grade 3/4 cardiac events and cardiac events leading to discontinuation of therapy were significantly higher in patients receiving 12 months (HR 2.06, 95% CI 1.60-2.63, P = 0.000, I2 3.967, p= 0.384). There was no significant heterogeneity among studies. Risk of bias was low. Conclusions: Twelve months of adjuvant T is associated with significantly better DFS and OS compared to a shorter duration. As such, 12 months should remain the standard of care for most patients. There is an unmet need to identify lower risk groups which might do well with from shorter duration of HER2-directed therapy.
Short-term Calorie Restriction and 17α-Estradiol Administration Elicit Divergent Effects on Proteostatic Processes and Protein Content in Metabolically Active Tissues
Miller, Benjamin F. , Pharaoh, Gavin , Hamilton, Karyn L. , Peelor, Fredrick F., Kirkland, James L. , Freeman, Willard M. , Mann, Shivani N. , Price, John C. , Freeman, Willard M , Kinter, Michael T , Stout, Michael B

Mayo Clinic

The Journals of Gerontology: Series A | May 10, 2019 | Volume: 75 | Issue: 5 | Pages: 849-857

10.1093/gerona/glz113 | PMID 31074767 Get It

Abstract17α-Estradiol (17α-E2) is a “non-feminizing” estrogen that extends life span in male, but not female, mice. We recently reported that 17α-E2 had robust beneficial effects on metabolic and inflammatory parameters in aged male mice. However, it remains unclear if 17α-E2 also delays other “hallmarks” of aging, particularly maintaining proteostasis. Here, we used isotope labeling methods in older mice to examine proteostatic mechanisms. We compared weight-matched mild calorie restricted (CR) and 17α-E2 treated male mice with the hypothesis that 17α-E2 would increase protein synthesis for somatic maintenance. 17α-E2 had no effect on protein synthesis or DNA synthesis in multiple tissues, including white adipose tissue. Conversely, mild short-term CR decreased DNA synthesis and increased the protein to DNA synthesis ratio in multiple tissues. Examination of individual protein synthesis and content did not differentiate treatments, although it provided insight into the regulation of protein content between tissues. Contrary to our hypothesis, we did not see the predicted differences in protein to DNA synthesis following 17α-E2 treatment. However, mild short-term CR elicited differences consistent with both lifelong CR and other treatments that curtail aging processes. These data indicated that despite similar maintenance of body mass, 17α-E2 and CR treatments elicit distinctly different proteostatic outcomes.
Mid-term radiological results of a cementless short humeral component in anatomical and reverse shoulder arthroplasty
Aibinder, William R. , Bartels, D , Sperling, John W. , Aibinder, William R , Sánchez‐Sotelo, Joaquín

Mayo Clinic

The Bone & Joint Journal | April 30, 2019 | Volume: 101-B | Issue: 5 | Pages: 610-614

10.1302/0301-620x.101b5.bjj-2018-1374.r1 | PMID 31039055 Get It

Aims Shoulder arthroplasty using short humeral components is becoming increasingly popular. Some such components have been associated with relatively high rates of adverse radiological findings. The aim of this retrospective review was to evaluate the radiological humeral bone changes and mechanical failure rates with implantation of a short cementless humeral component in anatomical (TSA) and reverse shoulder arthroplasty (RSA). Patients and Methods A total of 100 shoulder arthroplasties (35 TSA and 65 RSA) were evaluated at a mean of 3.8 years (3 to 8.3). The mean age at the time of surgery was 68 years (31 to 90). The mean body mass index was 32.7 kg/m2 (17.3 to 66.4). Results Greater tuberosity stress shielding was noted in 14 shoulders (two TSA and 12 RSA) and was graded as mild in nine, moderate in two, and severe in three. Medial calcar resorption was noted in 23 shoulders (seven TSA and 16 RSA), and was graded as mild in 21 and moderate in two. No humeral components were revised for loosening or considered to be loose radiologically. Nine shoulders underwent reoperation for infection (n = 3), fracture of the humeral tray (n = 2), aseptic glenoid loosening (n = 1), and instability (n = 3). No periprosthetic fractures occurred. Conclusion Implantation of this particular short cementless humeral component at the time of TSA or RSA was associated with a low rate of adverse radiological findings on the humeral side at mid-term follow-up. Our data do not raise any concerns regarding the use of a short stem in TSA or RSA. Cite this article: Bone Joint J 2019;101-B:610–614.
148. SHORT-FORM 36 AS A MEASURE OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GIANT CELL ARTERITIS
Kermani, Tanaz A. , Sreih, Antoine G. , Tómasson, Gunnar , Carette, Simon , Forbess, Lindsy, Koening, Curry L. , McAlear, Carol A. , Ytterberg, Steven R. , Langford, Carol A. , Cuthbertson, David , Borchin, Renée , Khalidi, Nader , Monach, Paul A. , Moreland, Larry W. , Pagnoux, Christian , Seo, Philip , Spiera, Robert , Warrington, Kenneth J. , Merkel, Peter A.

Mayo Clinic

Rheumatology | March 29, 2019 | Volume: 58 | Issue: Supplement_2 | Pages: No page available

10.1093/rheumatology/kez059.025 Get It